Javitt Jonathan C 4/A
4/A · NRX Pharmaceuticals, Inc. · Filed Jun 2, 2022
Insider Transaction Report
Form 4/AAmended
Javitt Jonathan C
DirectorChairman and Chief Scientist10% Owner
Transactions
- Purchase
Common Stock
2022-06-01$0.58/sh+100,000$58,000→ 146,332 total
Holdings
- 1,422,000(indirect: By Trust)
Common Stock
- 13,299,997(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Reflects charitable donations of 49,000 shares of Common Stock that occurred in December 2021.
- [F2]Held by the Jonathan Javitt Living Trust of which the Reporting Person is trustee.
- [F3]Held by The Javitt 2012 Irrevocable Dynasty Trust of which the Reporting Person is the Grantor.